Issues that need attention in the multi-sector approaches on providing anti-tuberculosis treatment for patients with diabetes mellitus-tuberculosis

doi:10.3969/j.issn.1000-6621.2021.07.002

Abstract

Abstract:

Both diabetes mellitus (DM) and tuberculosis (TB) are significant public health problem worldwide. Multi-sector approaches are recommended to treat patients with DM-TB. However, the multi-sector approaches should be patient-centered and supported with sufficient scientific evidences. This paper aimed to preliminary address issues in the multi-sector approaches during anti-TB treatment for patients with DM-TB. Views expressed in this paper are truly for discussion in the clinical practice.

Key words: Diabetes mellitus, Tuberculosis, Comorbidity, Multi-sector approach, Treatment and management

LIN Yan, DENG Guo-fang. Issues that need attention in the multi-sector approaches on providing anti-tuberculosis treatment for patients with diabetes mellitus-tuberculosis[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 649-652. doi: 10.3969/j.issn.1000-6621.2021.07.002

References 31

[1]	International Diabetes Federation. IDF Diabetes Atlas ninth edition 2019. Brussels: International Diabetes Federation, 2019.
[2]	Al-Rifai RH, Pearson F, Critchley JA, et al. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(11):e0187967. doi: 10.1371/journal.pone.0187967. doi: 10.1371/journal.pone.0187967 URL
[3]	Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health, 2018, 23(10):1058-1070. doi: 10.1111/tmi.13133. doi: 10.1111/tmi.13133 URL
[4]	Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn, 2007, 3(3):228-245. doi: 10.1177/1742395307081502. doi: 10.1177/1742395307081502 URL
[5]	Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med, 2008, 5(7):e152. doi: 10.1371/journal.pmed.0050152. doi: 10.1371/journal.pmed.0050152 URL
[6]	Corris V, Unwin N, Critchley J. Quantifying the association between tuberculosis and diabetes in the US: a case-control analysis. Chronic Illn, 2012, 8(2):121-134. doi: 10.1177/1742395312440294. doi: 10.1177/1742395312440294 URL
[7]	Reed GW, Choi H, Lee SY, et al. Impact of diabetes and smoking on mortality in tuberculosis. PLoS One, 2013, 8(2):e58044. doi: 10.1371/journal.pone.0058044. doi: 10.1371/journal.pone.0058044 URL
[8]	Huangfu P, Ugarte-Gil C, Golub J, et al. The effects of diabetes on tuberculosis treatment outcomes: an updated syste-matic review and meta-analysis. Int J Tuberc Lung Dis, 2019, 23(7):783-796. doi: 10.5588/ijtld.18.0433. doi: 10.5588/ijtld.18.0433 URL
[9]	Leung CC, Yew WW, Mok TYW, et al. Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis. Respirology, 2017, 22(6):1225-1232. doi: 10.1111/resp.13017. doi: 10.1111/resp.13017 pmid: 28244689
[10]	Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med, 2011, 9:81. doi: 10.1186/1741-7015-9-81. doi: 10.1186/1741-7015-9-81 URL
[11]	Liu Q, Li W, Xue M, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep, 2017, 7(1):1090. doi: 10.1038/s41598-017-01213-5. doi: 10.1038/s41598-017-01213-5 URL
[12]	Golub JE, Mok Y, Hong S, et al. Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality. Int J Tuberc Lung Dis, 2019, 23(4):507-513. doi: 10.5588/ijtld.18.0103. doi: 10.5588/ijtld.18.0103 URL
[13]	Harries AD, Kumar AM, Satyanarayana S, et al. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis, 2015, 19(8):879-886. doi: 10.5588/ijtld.15.0069. doi: 10.5588/ijtld.15.0069 URL
[14]	Pan SC, Ku CC, Kao D, et al. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol, 2015, 3(5):323-330. doi: 10.1016/S2213-8587(15)00042-X. doi: 10.1016/S2213-8587(15)00042-X URL
[15]	Lin Y, Harries AD, Kumar AM, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice[EB/OL].[2021-05-12]. https://www.theunion.org/what-we-do/publications/technical/english/TheUnion_DMTB_Guide.pdf.
[16]	Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia, 2018, 61(6):1249-1260. doi: 10.1007/s00125-018-4557-7. doi: 10.1007/s00125-018-4557-7 URL
[17]	Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 2017, 317(24):2515-2523. doi: 10.1001/jama.2017.7596. doi: 10.1001/jama.2017.7596 URL
[18]	Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA, 2013, 310(9):948-958. doi: 10.1001/jama.2013.168118. doi: 10.1001/jama.2013.168118 URL
[19]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1):12-22. doi: 10.3969/j.issn.1000-6621.2021.01.004. doi: 10.3969/j.issn.1000-6621.2021.01.004
[20]	Crevel RV, Critchley JA. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice. Trop Med Infect Dis, 2021, 6(1):8. doi: 10.3390/tropicalmed6010008. doi: 10.3390/tropicalmed6010008
[21]	Lin Y, Yuan Y, Zhao X, et al. The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China. Glob Health Action, 2017, 10(1):1289737. doi: 10.1080/16549716.2017.1289737. doi: 10.1080/16549716.2017.1289737 URL
[22]	Harries AD, Kumar AM, Satyanarayana S, et al. Communicable and non-communicable diseases: connections, synergies and benefits of integrating care. Public Health Action, 2015, 5(3):156-157. doi: 10.5588/pha.15.0030. doi: 10.5588/pha.15.0030 pmid: 26393110
[23]	Magee MJ, Salindri AD, Gujral UP, et al. Convergence of non-communicable diseases and tuberculosis: a two-way street? Int J Tuberc Lung Dis, 2018, 22(11):1258-1268. doi: 10.5588/ijtld.18.0045. doi: 10.5588/ijtld.18.0045
[24]	Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, et al. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med, 2016, 164(8):542-552. doi: 10.7326/M15-3016. doi: 10.7326/M15-3016
[25]	Standards of Medical Care in Diabetes-2017. Diabetes Care, 2017, 40(Suppl 1):S4-S5. doi: 10.2337/dc17-S003. doi: 10.2337/dc17-S003 URL
[26]	Qaseem A, Wilt TJ, Kansagara D, et al. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Gui-dance Statement Update From the American College of Physicians. Ann Intern Med, 2018, 168(8):569-576. doi: 10.7326/M17-0939. doi: 10.7326/M17-0939 pmid: 29507945
[27]	van Crevel R, Koesoemadinata R, Hill PC, et al. Clinical management of combined tuberculosis and diabetes. Int J Tuberc Lung Dis, 2018, 22(12):1404-1410. doi: 10.5588/ijtld.18.0340. doi: 10.5588/ijtld.18.0340
[28]	Dlodlo RA, Brigden G, Heldal E, et al. Management of tuberculosis: a guide to essential practice[EB/OL]. [2021-05-12]..
[29]	Lin Y, Harries AD. Tuberculosis infection control measures in diabetes clinics in China: a rapid assessment of 10 hospitals. Trop Med Int Health, 2015, 20(9):1196-1200. doi: 10.1111/tmi.12537. doi: 10.1111/tmi.12537 URL
[30]	Degner NR, Wang JY, Golub JE, et al. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment. Clin Infect Dis, 2018, 66(2):198-205. doi: 10.1093/cid/cix819. doi: 10.1093/cid/cix819 URL
[31]	Singhal A, Jie L, Kumar P, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med, 2014, 6(263): 263ra159. doi: 10.1126/scitranslmed.3009885. doi: 10.1126/scitranslmed.3009885 URL